If they were expecting delays, would they not have been required to update the schedule portion of the prospectus when they shifted the costs to 2018? There has to be more to the story, but I cannot assume it is bad until we know that it is bad. This team does not have a history of "bad" so that will not be my first assumption. I'm going with somewhere between neutral and good.
Did any of the QTR 3 milestones get pushed into 2018? Seems to me it would be considered a bad thing if that happened. But simply shifting costs from one quarter to future quarters yet keeping the same timeline schedule doesn't seem to reach the level of "delays". But as always, I'm not an expert in this field. So I'll defer to others who are much more versed in this arena.
News 
Market Data 
Discover 
AI
